Hematologically important mutations: Glanzmann thrombasthenia

Blood Cells, Molecules and Diseases

Volumn 23, Issue 1, 1997, Pages 39-51

  French, Deborah L ^a   Coller, Barry S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; CAPILLARY RESISTANCE; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GLANZMANN DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030857775     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1997.0117     Document Type: Article

References (65)

1. George J N, Caen J P, Nurden A T. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood. 75:1990;1383-1395.
2. Coller B S, Seligsohn U, Peretz H, Newman P J. Glanzmann thrombasthenia: New insights from an historical perspective. Semin Hematol. 31:1994;301-311.
3. Poncz M, Eisman R, Heidenreich R. Structure of the platelet membrane glycoprotein IIb. J Biol Chem. 262:1987;8476-8482.
4. Fitzgerald L A, Steiner B, Rall S C Jr., Lo S, Phillips D R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. J Biol Chem. 262:1987;3936-3939.
5. Beaudet A K, Antonarakis S E, Beutler E. Update on nomenclature for human gene mutations. Hum Mutat. 8:1996;197-202.
6. Beutler E, McKusick V A, Motulsky A G, Scriver C R, Hutchinson F. Mutation nomenclature: Nicknames, systematic names, and unique identifiers. Hum Mutat. 8:1996;203-206.
7. Burk C D, Newman P J, Lyman S, Gill J, Coller B S, Poncz M. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia. J Clin Invest. 87:1991;270-276.
8. Coller B S, Seligsohn U, Zivelin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel: comparison of techniques for carrier detection. Br J Haematol. 62:1986;723-735.
9. Coller B S, Seligsohn S, Little P A. Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood. 69:1987;1969-1703.
10. Seligsohn U, Coller B S, Zivelin A, Plow E F, Ginsberg M H. Immunoblot analysis of platelet glycoprotein IIb in patients with Glanzmann thrombasthenia in Israel. Br J Haematol. 72:1989;415-423.
11. Coller B S, Cheresh D A, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 77:1991;75-83.
12. Newman P J, Seligsohn U, Lyman S, Coller B S. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA. 88:1991;3160-3164.
13. Kirchmaier C M, Westrup D, Becker-Hagendorff K, Just M, Jablonka B, Seifried E. A new variant of Glanzmann thrombasthenia (Frankfurt I). Thromb Haemost. 73:1995;1058.
14. Chen F P, Coller B S, Weiss H J, Xu L Z, French D L. Glanzmann thrombasthenia due to a glycoprotein IIb missense mutation Leu214Pro. Thromb Haemost. 73:1995;1191.
15. C, M, Grimaldi, F, P, Chen, C, H, Wu, H, J, Weiss, B, S, Coller, D, L, French, 1997, Glanzmann thrombasthenia due to a glycoprotein IIb missense mutation Leu214Pro identifies a region important in ligand binding.
16. Poncz M, Rifat S, Coller B S, Newman P J, Shattil S J, Parrella T, Fortina P, Bennett J S. Glanzmann thrombasthenia secondary to a Gly273Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest. 93:1994;172-179.
17. ++. Blood. 86:1995;452a.
18. Wilcox D A, Paddock C M, Lyman S, Gill J C, Newman P J. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. J Clin Invest. 95:1995;1553-1560.
19. Ferrer M, Fernandez-Pinel M, Gonzalez-Manchon C, Gonzalez J, Ayuso M S, Parrilla R. A mutant (Arg327→His) GPIIb associated to thrombathenia exerts a dominant negative effect in stably transfected CHO cells. Thromb and Haemost. 76:1996;292-301.
20. IIbIIb3. J Biol Chem. 269:1994;4450-4457.
21. IIbIIb3. Blood. 88:1996;167-173.
22. IIb. Blood. 86:1995;977-982.
23. French D L, Chen F P, Xu L, Coller B S. A common Arg584Stop mutation in glycoprotein (GP) IIb in 2 additional patients with Glanzmann thrombasthenia. Blood. 88:1996;30a.
24. Moroi M, Yamamura J, Koga H, Miyazaki S, Jung S M. Analysis of a variant form of platelet glycoprotein (GP) IIb: a second patient with abnormal molecular weight GPIIb. Thromb Res. 62:1991;217-225.
25. Kato A, Yamamoto K, Miyazaki S, Jung S M, Moroi M, Aoki N. Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: A proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex. Blood. 79:1992;3212-3218.
26. Ruan C G, Gu J M, Wang X D, Chu X H, Pan J L. Application of GPIIIa gene Taq I polymorphism to determination of carrier status in Glanzmann's thrombasthenia families of Chinese origin. Thromb Haemost. 68:1993;64-69.
27. Gu J M, Xu W F, Wang X D, Wu Q Y, Chi C W, Ruan C G. Identification of a nonsense mutation at amino acid 584-arginine of platelet glycoprotein IIb in patients with type I Glanzmann thrombasthenia. Br J Haematol. 83:1993;442-449.
28. Vinciguerra C, Trzeciak M C, Philippe N. Molecular study of Glanzmann thrombasthenia in 3 patients issued from 2 different families. Thromb Haemost. 74:1994;822-827.
29. Tomiyama Y, Kashiwagi H, Kosugi S. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia. Br J Haematol. 87:1994;119-124.
30. Tomiyama Y, Kashiwagi H, Kosugi S. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia. Thromb Haemost. 73:1995;756-762.
31. Peretz H, Rosenberg N, Usher S. Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene. Blood. 85:1995;414-420.
32. Iwamoto S, Nishiumi E, Kajii E, Ikemoto S. An exon 28 mutation resulting in alternative splicing of the glycoprotein IIb transcript and Glanzmann's thrombasthenia. Blood. 83:1994;1017-1023.
33. Kolodziej M A, Vilaire D, Rifat S, Poncz M, Bennett J S. Effect of deletion of glycoprotein Iib exon 28 on the expression of the platelet glycoprotein Iib/IIIa complex. Blood. 78:1991;22344-22353.
34. Weiss H J, Turitto V T, Baumgartner H R. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 67:1986;322-330.
35. D, L, French, F, P, Chen, L, Xu, H, J, Weiss, B, S, Coller, 1997, Two unrelated doubly heterozygous patients with Glanzmann thrombasthenia have the same GPIIb mutation resulting in loss of the transmembrane domain, XVIth Congress of the ISTH, Florence, Italy.
36. Weiss H J, Kockwa S. Studies of platelet function and proteins in three patients with Glanzmann thrombasthenia. J Lab Clin Med. 71:1968;153-165.
37. Hardisty R, Pidard D, Cox A. A defect of platelet aggregation with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet. Blood. 80:1992;696-708.
38. IIb. Thromb Haemost. 73:1995;1189.
39. Simsek S, Heyboer H, de Bruijne-Admiraal L G, Goldschmeding R, Cuijpers H TM, von dem Borne A EGK. Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA. Blood. 81:1993;2044-2049.
40. IIb. Blood. 88:1996;32a.
41. Ginsberg M H, Lightsey A, Kunicki T J, Kaufmann A, Marguerie G, Plow E F. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest. 78:1986;1103-1111.
42. 3. Science. 249:1990;915-918.
43. C, Ward, Y, L, Chao, P, Bray, P, J, Newman, 1997.
44. 3. Blood. 88:1996;280a.
45. A2. Blood. 88:1996;3831-3836.
46. 214214. J Clin Invest. 89:1992;1995-2004.
47. Kouns W C, Steiner B, Kunicki T J. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood. 84:1994;1108-1115.
48. Nurden A T, Rosa J-P, Fournier D. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. J Clin Invest. 79:1987;962-969.
49. 3. Hum Mol Genet. 2:1993;2179-2180.
50. Fournier D J, Kabral A, Castaldi P A, Berndt M C. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation. Thromb Haemost. 62:1989;977-983.
51. IIb3. J Biol Chem. 267:1992;3789-3794.
52. Newman P J, Weyerbusch-Bottum S, Visentin G P, Gidwitz S, White G C II. Type II Glanzmann thrombasthenia due to a destabilizing amino acid substitution in platelet membrane glycoprotein IIIa. Thromb Haemost. 69:1993;1017.
53. Bray P F, Shuman M A. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann thrombasthenia. Blood. 75:1990;881-888.
54. Li L, Bray P G. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am J Hum Genet. 53:1993;140-149.
55. Jin Y, Dietz H C, Nurden A, Bray P F. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood. 82:1993;2281-2288.
56. C, Ward, A, Kestin, P, J, Newman, 1997.
57. 3. Blood. 88:1996;1666-1675.
58. Grimaldi C M, Coller B S, French D L. The GPIIIa Cys374-Cys386 disulfide loop is important for biosynthesis and function of the GPIIb/IIIa receptor. Blood. 88:1996;279a.
59. 3. Hum Mol Genet. 2:1993;2183-2185.
60. Jin Y, Dietz H C, Montgomery R A. Glanzmann thrombasthenia. Cooperation between sequence variants incis. J Clin Invest. 98:1996;1745-1754.
61. 3IIb3. Blood. 84:1994;244a.
62. 3. Blood. 1997.
63. 3IIb3. Proc Natl Acad Sci USA. 89:1992;10169-10173.
64. IIb3. Blood. 84:1994;1857-1865.
65. 3. J Biol Chem. 270:1995;9550-9557.